Long-term Follow-up of Long-acting Cabotegravir (CAB LA) for PrEP (Pre-exposure Prophylaxis) in Participants at Risk of Acquiring HIV (Human Immunodeficiency Virus)

Name: Long-term Follow-up of Long-acting Cabotegravir (CAB LA) for PrEP (Pre-exposure Prophylaxis) in Participants at Risk of Acquiring HIV (Human Immunodeficiency Virus)
Published: 2024
License: Public Domain

ViiV Healthcare · 2024

ClinicalTrials.gov · Datasets · License: Public Domain · 2024

Open Source ↗

hiv hiv-infections human-immunodeficiency-virus prep

hiv infections, hiv, human immunodeficiency virus, cab la, cabotegravir, apretude, prep, hptn 083, hptn 084, daids, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Long-term Follow-up of Long-acting Cabotegravir (CAB LA) for PrEP (Pre-exposure Prophylaxis) in Participants at Risk of Acquiring HIV (Human Immunodeficiency Virus)

Related documents